DCF — WINCHESTER MEDICAL CENTER
Enterprise Value: $-695.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-695.8M
Enterprise Value
$-229.6M
PV of Cash Flows
$-466.3M
PV of Terminal Value
$-750.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $715.5M | $-38.2M | -5.0% | $-68.5M | $-62.3M |
| Year 2 | $737.0M | $-32.0M | -4.0% | $-63.2M | $-52.2M |
| Year 3 | $759.1M | $-25.4M | -3.0% | $-57.5M | $-43.2M |
| Year 4 | $781.8M | $-22.2M | -3.0% | $-55.3M | $-37.8M |
| Year 5 | $805.3M | $-20.9M | -3.0% | $-54.9M | $-34.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-695.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$694.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05840180040994563
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5